Form 6-K Ridgetech Inc. For: Aug 05

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934

 

For the month of August 2026

 

Commission File Number: 001-40724

 

RIDGETECH, INC.
(Translation of registrant’s name into English)

 

5th Floor, Building 6, No. 100, 18th Street, Baiyang Sub-district,

Qiantang District, Hangzhou City, Zhejiang Province, People’s Republic of China, 310018
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F ☒        Form 40-F ☐

 

 

 

Ridgetech, Inc., a Cayman Islands exempted company (the “Company”) furnishes under the cover of Form 6-K the following in connection with its annual general meeting of the shareholders:

 

Exhibit No.		Description of Exhibit
99.1		Proxy Statement for the Annual General Meeting of the Shareholders
99.2		Form of Proxy Card*
99.3		Form of Notice Regarding the Availability of Proxy Materials

 

*	Note to shareholders of the Company: The proxy card furnished hereto is a form for your reference only. You shall vote based on the proxy card you receive.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: August 5, 2026	RIDGETECH, INC.
	By:	/s/ Ming Zhao
	Name:	Ming Zhao
	Title:	Interim Chief Executive Officer and Chief Financial Officer

 

 

ATTACHMENTS / EXHIBITS

PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING OF THE SHAREHOLDERS

FORM OF PROXY CARD

FORM OF NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• “Tea Chat with Ambassadors in Shanxi” & International Dialogue on Energy and Low-carbon Development Successfully Held in Taiyuan.
• Accro Bioscience Announces Inclusion of AC-101 tablets in the NMPA CDE's "Caring Plan-Extension" Pilot Program for Rare Disease Drug Development
• Report About the 1993 WWE Survivor Series Published by Pardu Productions